144 related articles for article (PubMed ID: 38001674)
1. Bilaterality as a Risk Factor for Recurrence in Papillary Thyroid Carcinoma.
Kim H; Kwon H
Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001674
[TBL] [Abstract][Full Text] [Related]
2. Multifocality, but not bilaterality, is a predictor of disease recurrence/persistence of papillary thyroid carcinoma.
Kim HJ; Sohn SY; Jang HW; Kim SW; Chung JH
World J Surg; 2013 Feb; 37(2):376-84. PubMed ID: 23135422
[TBL] [Abstract][Full Text] [Related]
3. Significance of multifocality in papillary thyroid carcinoma.
Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
[TBL] [Abstract][Full Text] [Related]
4. Number of Tumor Foci as a Risk Factor for Recurrence in Papillary Thyroid Carcinoma: Does It Improve Predictability?
Kwon H; Lim W; Moon BI
Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077678
[TBL] [Abstract][Full Text] [Related]
5. Bilaterality weighs more than unilateral multifocality in predicting prognosis in papillary thyroid cancer.
Qu N; Zhang L; Wu WL; Ji QH; Lu ZW; Zhu YX; Lin DZ
Tumour Biol; 2016 Jul; 37(7):8783-9. PubMed ID: 26743781
[TBL] [Abstract][Full Text] [Related]
6. Impact of Multifocality on the Recurrence of Papillary Thyroid Carcinoma.
Woo J; Kim H; Kwon H
J Clin Med; 2021 Nov; 10(21):. PubMed ID: 34768664
[TBL] [Abstract][Full Text] [Related]
7. Bilateral multifocality is an independent predictor of patients' outcome in Middle Eastern papillary thyroid carcinoma.
Parvathareddy SK; Siraj AK; Annaiyappanaidu P; Siraj N; Al-Sobhi SS; Al-Dayel F; Al-Kuraya KS
Front Endocrinol (Lausanne); 2022; 13():1060301. PubMed ID: 36686467
[TBL] [Abstract][Full Text] [Related]
8. Multifocality of papillary thyroid carcinoma as a risk factor for disease recurrence.
Choi WR; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2019 Jul; 94():106-110. PubMed ID: 31178204
[TBL] [Abstract][Full Text] [Related]
9. The appropriateness of thyroid lobectomy as an initial surgery for preoperatively detected unilateral multifocal papillary carcinoma.
Albinsaad LS; Kim WW; Lee YM; Sung TY; Chung KW; Hong SJ
Asian J Surg; 2021 Aug; 44(8):1050-1055. PubMed ID: 33573922
[TBL] [Abstract][Full Text] [Related]
10. Clinical Implication of Bilateral and Unilateral Multifocality in Papillary Thyroid Carcinoma: A Propensity Score-Matched Study.
Kim Y; An S; Park J; Bae JS; Kim JS; Kim K
Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509259
[TBL] [Abstract][Full Text] [Related]
11. Predicting Factors for Bilaterality in Papillary Thyroid Carcinoma with Tumor Size <4 cm.
Kim SK; Park I; Woo JW; Lee JH; Choe JH; Kim JH; Kim JS
Thyroid; 2017 Feb; 27(2):207-214. PubMed ID: 27750022
[TBL] [Abstract][Full Text] [Related]
12. Pathological multifocality is not a prognosis factor of papillary thyroid carcinoma: a single-center, retrospective study.
Omi Y; Haniu K; Kamio H; Fujimoto M; Yoshida Y; Horiuchi K; Okamoto T
World J Surg Oncol; 2022 Dec; 20(1):394. PubMed ID: 36510206
[TBL] [Abstract][Full Text] [Related]
13. Optimal Surgical Extent in Patients with Unilateral Multifocal Papillary Thyroid Carcinoma.
Woo J; Kwon H
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053595
[TBL] [Abstract][Full Text] [Related]
14. Bilaterality, not multifocality, is an independent risk factor for recurrence in low-risk papillary thyroid cancer.
Rodriguez Schaap PM; Lin JF; Metman MJH; Dreijerink KMA; Links TP; Bonjer HJ; Nieveen van Dijkum EJM; Dickhoff C; Kruijff S; Engelsman AF
J Natl Cancer Inst; 2023 Sep; 115(9):1071-1076. PubMed ID: 37267155
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the clinicopathologic features and prognosis of bilateral versus unilateral multifocal papillary thyroid cancer: An updated study with more than 2000 consecutive patients.
Wang W; Su X; He K; Wang Y; Wang H; Wang H; Zhao Y; Zhao W; Zarnegar R; Fahey TJ; Teng X; Teng L
Cancer; 2016 Jan; 122(2):198-206. PubMed ID: 26506214
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of the sum of the diameters of single foci in multifocal papillary thyroid cancer: the concept of new-old tumor burden.
Manso J; Censi S; Roberti A; Iacobone M; Barollo S; Bertazza L; Galuppini F; Vianello F; Albinger N; Scaroni C; Pennelli G; Mian C
Ther Adv Endocrinol Metab; 2020; 11():2042018820964326. PubMed ID: 33110488
[TBL] [Abstract][Full Text] [Related]
17. Clinical and prognosis value of the number of metastatic lymph nodes in patients with papillary thyroid carcinoma.
Zhan L; Feng HF; Yu XZ; Li LR; Song JL; Tu Y; Yuan JP; Chen C; Sun SR
BMC Surg; 2022 Jun; 22(1):235. PubMed ID: 35725426
[TBL] [Abstract][Full Text] [Related]
18. Total tumor diameter: the neglected value in papillary thyroid microcarcinoma.
Feng JW; Pan H; Wang L; Ye J; Jiang Y; Qu Z
J Endocrinol Invest; 2020 May; 43(5):601-613. PubMed ID: 31749082
[TBL] [Abstract][Full Text] [Related]
19. The Prognostic Value of Tumor Multifocality in Clinical Outcomes of Papillary Thyroid Cancer.
Wang F; Yu X; Shen X; Zhu G; Huang Y; Liu R; Viola D; Elisei R; Puxeddu E; Fugazzola L; Colombo C; Jarzab B; Czarniecka A; Lam AK; Mian C; Vianello F; Yip L; Riesco-Eizaguirre G; Santisteban P; O'Neill CJ; Sywak MS; Clifton-Bligh R; Bendlova B; Sýkorová V; Wang Y; Liu S; Zhao J; Zhao S; Xing M
J Clin Endocrinol Metab; 2017 Sep; 102(9):3241-3250. PubMed ID: 28582521
[TBL] [Abstract][Full Text] [Related]
20. [Incidence and Predictive Factors for Bilaterality in Patients with Papillary Thyroid Carcinoma].
Jo P; Kesruek H; Nietert M; Sahlmann CO; Gaedcke J; Ghadimi M; Sperling J
Zentralbl Chir; 2018 Aug; 143(4):361-366. PubMed ID: 30134494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
